Anixa Biosciences, Inc. (NASDAQ:ANIX – Get Free Report) was the target of a significant decrease in short interest in May. As of May 15th, there was short interest totalling 554,300 shares, a decrease of 12.3% from the April 30th total of 632,100 shares. Approximately 1.8% of the shares of the stock are sold short. Based […]